149 related articles for article (PubMed ID: 8167687)
1. Primary severe immunodeficiency due to impaired signal transduction in T cells.
Schlesier M; Niemeyer C; Duffner U; Henschen M; Tanzi-Fetta R; Wolff-Vorbeck G; Dräger R; Brandis M; Peter HH
Immunodeficiency; 1993; 4(1-4):133-6. PubMed ID: 8167687
[No Abstract] [Full Text] [Related]
2. Severe combined immunodeficiency due to a specific defect in the production of interleukin-2.
Weinberg K; Parkman R
N Engl J Med; 1990 Jun; 322(24):1718-23. PubMed ID: 2342538
[No Abstract] [Full Text] [Related]
3. Induction of responsiveness in lymphocytes of immunodeficient patients' cells implanted with foreign plasma membranes.
Levy D; Porat Y; Pick I; Handzel ZT; Schlesinger M; Tanay A; Zan-Bar I
Immunodeficiency; 1993; 4(1-4):43-6. PubMed ID: 8167731
[No Abstract] [Full Text] [Related]
4. [T cell receptor, immunoglobulin genes and immunodeficiency].
Kurosawa Y
Tanpakushitsu Kakusan Koso; 1991 Aug; 36(10):1741-6. PubMed ID: 1947183
[No Abstract] [Full Text] [Related]
5. Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function.
Bao JY; Huang Y; Wang F; Peng YP; Qiu YH
Neuroimmunomodulation; 2007; 14(6):344-53. PubMed ID: 18463421
[TBL] [Abstract][Full Text] [Related]
6. A critical role for IL-21 in regulating immunoglobulin production.
Ozaki K; Spolski R; Feng CG; Qi CF; Cheng J; Sher A; Morse HC; Liu C; Schwartzberg PL; Leonard WJ
Science; 2002 Nov; 298(5598):1630-4. PubMed ID: 12446913
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4.
Yu CR; Kirken RA; Malabarba MG; Young HA; Ortaldo JR
J Immunol; 1998 Jul; 161(1):218-27. PubMed ID: 9647227
[TBL] [Abstract][Full Text] [Related]
8. [Common variable immunodeficiency].
Saiki O
Rinsho Byori; 1985 Nov; 33(11):1203-9. PubMed ID: 2419600
[No Abstract] [Full Text] [Related]
9. [Severe combined immunodeficiency disease. I. Patients with SCID--clinical features and immunological findings].
Matsuoka H; Torii S; Okada J; Mizuno T; Tsuge I; Katagiri M; Kishimoto M; Sato C; Matsuoka M; Suzuki S
Arerugi; 1984 Dec; 33(12):1002-7. PubMed ID: 6335963
[No Abstract] [Full Text] [Related]
10. Lack of interleukin-2 production in a patient with OKT4+ T-cell deficiency.
Tsuchiya S; Imaizumi M; Minegishi M; Konno T; Tada K
N Engl J Med; 1983 May; 308(21):1294. PubMed ID: 6601773
[No Abstract] [Full Text] [Related]
11. [Severe combined immunodeficiency disease. II. Heterogeneity of B cell defects observed in patients with "SCID having B cells"].
Matsuoka H; Torii S; Okada J; Mizuno T; Tsuge I; Matsuoka M
Arerugi; 1985 Jan; 34(1):1-5. PubMed ID: 3873232
[No Abstract] [Full Text] [Related]
12. Genetic analysis of the human CD3-epsilon gene in a T cell receptor/CD3 immunodeficiency.
Soudais C; De Villartay JP; Le Deist F; Fischer A; Lisowska-Grospierre B
Immunodeficiency; 1993; 4(1-4):117-9. PubMed ID: 8167684
[No Abstract] [Full Text] [Related]
13. Primary immunodeficiency diseases. Report prepared for the WHO by a scientific group on immunodeficiency.
Clin Immunol Immunopathol; 1983 Sep; 28(3):450-75. PubMed ID: 6349887
[No Abstract] [Full Text] [Related]
14. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
15. Relationship between IL 2 synthesis and the proliferative response to PHA in different primary immunodeficiencies.
López-Botet M; Fontán G; Garcia Rodriguez MC; de Landázuri MO
J Immunol; 1982 Feb; 128(2):679-83. PubMed ID: 6976384
[No Abstract] [Full Text] [Related]
16. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
[TBL] [Abstract][Full Text] [Related]
17. Immunodeficiency is a tough nut to CRAC: the importance of calcium flux in T cell activation.
Carroll HP; McNaull BB; Gadina M
Mol Interv; 2006 Oct; 6(5):253-6. PubMed ID: 17035665
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
19. Immune deficiency of the uremic patient.
Chatenoud L; Herbelin A; Beaurain G; Descamps-Latscha B
Adv Nephrol Necker Hosp; 1990; 19():259-74. PubMed ID: 2105582
[No Abstract] [Full Text] [Related]
20. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation.
Liston A; Enders A; Siggs OM
Nat Rev Immunol; 2008 Jul; 8(7):545-58. PubMed ID: 18551129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
